All News #Library
Biotech
Stealth Bio Provides Launch Update & Pipeline Progress
30 Apr 2026 //
PR NEWSWIRE
Stealth Bio Receives MRC Grant For Mitochondrial Disease Research
23 Mar 2026 //
PR NEWSWIRE
Stealth Bio Outlines 2026 Commercial And R&D Strategy
06 Jan 2026 //
PR NEWSWIRE
Stealth Bio Unveils Mito Assist Program, Partners with AnovoRx
09 Oct 2025 //
PR NEWSWIRE
Stealth Bio to Present Bevemipretide Data at ARVO Meeting
24 Apr 2025 //
PR NEWSWIRE
Stealth biotech bags rights to VelaVigo bispecific in $440M deal
21 Apr 2025 //
FIERCE BIOTECH
Stealth BioTherapeutics To Present At UBS Ophthalmology Day
27 Sep 2024 //
PR NEWSWIRE
Stealth BioTherapeutics Shares Bevemipretide Data on Macular Degeneration
18 Sep 2024 //
PR NEWSWIRE
Stealth BioTherapeutics To Participate In Ophthalmology Conferences
12 Sep 2024 //
PR NEWSWIRE
FDA Advisory Committee To Review Stealth`s Elamipretide For Barth Syndrome
09 Sep 2024 //
PR NEWSWIRE
Stealth BioTherapeutics Completes Mid-Cycle Review For Elamipretide In Barth
29 Jul 2024 //
PR NEWSWIRE
Stealth Bio: First Patient In Phase 3 Elamipretide For Dry AMD
05 Jun 2024 //
PR NEWSWIRE
Stealth Announces Positive Phase 2 Meeting with FDA ragrading Elamipretide
12 Jun 2023 //
PR NEWSWIRE

Market Place
Sourcing Support